Insights

The view from the ‘thing end’ of the IoT makes a lot of edge computing seem huge, but the true edge of the IoT is where the electronics end. For this reason, we need to look towards technologies that...

Can Unmanned Aerial Vehicles (UAVs or “drones”) ever mix safely with existing air traffic? Recent news suggests that the Federal Aviation Authority in the US thinks so...

In April of this year the use of neonicotinoid in all outdoor crop applications was banned. So why are these particular insecticides particularly harmful to bees?

To understand the current usage and future potential of liquid biopsy, we brought together experts from a range of disciplines to answer the following question: What is the current and future clinical utility of liquid biopsy based testing in oncology?

As a keen fan of Formula 1, I’m amazed at the start of each season (especially those that follow a major rule change) that the teams manage to produce brand new cars from scratch, capable of performing...

“What does the youngest chief executive in Big Pharma want? A control room straight off the starship Enterprise.”… That was the headline of a recent Forbes article on the vision of the new Novartis CEO, Vasant Narsimhan...

Could we replace fossil fuel-derived polymers with plastics that have been made from renewable resources and/or could biodegrade naturally at the end of their life?

Our new whitepaper looks at the potential of PHA bioplastics in the food service industry. We've designed a range of biodegradable plastic products, all served up on a bioplastic tray...

Eddy Merckx dominated professional cycling, the 'Amazon' of his era. Other teams had to innovate or retire. Warehouse automation faces the same challenge.

Following the proposed ban on plastic straws and cotton buds in England, our new infographic shows how versatile bioplastics could help.

The emerging field of biodesign has famously led to apples that do not go brown, meat burgers that don’t require livestock and spider-less silk. Biodesign is also widely harnessed to develop life-changing drugs, create...

The era of clinical trials as we’ve known them, is coming to an end. Rising costs, coupled with the commercial risks of failure, are unsustainable. This disruptive state is driving the adoption of new technologies, and catalysing...